The association between internal polycyclic aromatic hydrocarbons exposure and risk of Obesity-A systematic review with meta-analysis

Chemosphere. 2023 Jul:329:138669. doi: 10.1016/j.chemosphere.2023.138669. Epub 2023 Apr 12.

Abstract

Exposure to polycyclic aromatic hydrocarbons (PAHs) is emerging as a risk factor for obesity, but with conflicting findings. The aim of this systematic review is to investigate and summarize the current evidence towards the associations between PAHs exposure and risk of obesity. We conducted a systematic search of online databases, including PubMed, Embase, Cochrane Library, and Web of Science up to April 28, 2022. Eight cross-sectional studies with data from 68,454 participants were included. The present study illustrated that there was a significant positive association between naphthalene (NAP), phenanthrene (PHEN), and total OH-PAH metabolites and risk of obesity, the pooled OR (95% CI) was estimated at 1.43 (1.07, 1.90), 1.54 (1.18, 2.02), and 2.29 (1.32, 3.99), respectively. However, there was no significant association between fluorene (FLUO) and1-hydroxypyrene (1-OHP) metabolite and risk of obesity. Subgroup analyses showed that associations between PAHs exposure and risk of obesity were more apparent in children, female, smokers and developing regions.

Keywords: Meta-analysis; Obesity; Polycyclic aromatic hydrocarbons; Systematic review.

Publication types

  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Biomarkers
  • Child
  • Cross-Sectional Studies
  • Female
  • Humans
  • Obesity / chemically induced
  • Obesity / epidemiology
  • Polycyclic Aromatic Hydrocarbons*
  • Risk Factors

Substances

  • Polycyclic Aromatic Hydrocarbons
  • Biomarkers